Researchers are excited about Retatrutide , a novel dual agonist showing remarkable results in initial trials for weight management. It acts by modulating two pathways : GLP-1 and GIP, which , when https://hamzahgcft507613.designi1.com/61483310/a-new-hope-for-size-loss